Dr Allen Jeremias (St. Francis Hospital, Roslyn, NY, US) discusses the DEFINE PCT Trial - Blinded assessment of residual ischaemia after successful angiographic PCI.

Filmed on site at ACC 2019 by Radcliffe Cardiology

Questions:

1. What is DEFINE PCI and why is it needed?

2. What is the study design and endpoints?

3. What were your findings?

4. How should this trial impact practice ?

5. How will DEFINE PCI influence future research in post-PCI coronary physiology ?

Videography: Josh Birch

Interviewer: Liam O’Neill